ARCHIVES

NCI Pulls Back Curtain on “Zone of Uncertainty” — Funding Patterns Released With Little Comment

This article is from The Cancer Letter archive.

Vol. 38 No. 18 | May 4, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Programs: First Raid Awardees, Drug Development Projects, Listed

March 26, 1999

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

July 25, 2008

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

July 20, 1990

ACCC/Oncology Economic Meeting to Examine DRGs, FCCs, Quality

August 9, 1985

‘Major Discover’ At FCRDC Is NF1 Gene, Report Says

November 30, 1990

CCOP Recompetition Approved By NCAB

May 23, 1986